TITAN PHARMACEUTICALS INC (TTNP)

Company Profile

Titan Pharmaceuticals Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in San Francisco, California and currently employs 4 full-time employees. Titan Pharmaceuticals, Inc. is a pharmaceutical company. The firm is engaged in developing therapeutics utilizing its long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. Its ProNeura continuous drug delivery system consists of a small, solid rod-shaped implant made from a mixture of ethylene-vinyl acetate (EVA), and a drug substance. Its first product, Probuphine (buprenorphine implant), is based on ProNeura technology, which is used for the maintenance treatment of opioid use disorder in clinically stable patients taking 8 milligrams (mg) or less a day of oral buprenorphine. Its product pipeline includes the Kappa Opioid Receptor Agonist (TP-2021) Implant and Nalmefene Implant. Its TP-2021 is used for the treatment of moderate-to-severe chronic pruritus. Its Nalmefene Implant is used for the prevention of relapse in opioid use disorder (OUD) patients following detoxification from opioids.

Company Info

TITAN PHARMACEUTICALS INC

Suite 505, 400 Oyster Point Blvd

San Francisco CALIFORNIA 94080

P: 14152444990

CEO: Marc Rubin

Employees: 4

Website: https://www.titanpharm.com/